SummitTX Capital’s Albemarle ALB Stock Holding History

SummitTX Capital’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,276	Closed	-$428K	–	685
2025 Q3	$428K	Buy	+5,276	New	+$407K	0.02%	553

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SummitTX Capital's ALB Position: Q4 2025 in Review

SummitTX Capital sold out of Albemarle (ALB) in Q4 2025, closing a stake of 5,276 shares — an estimated $428K sold.

SummitTX Capital first reported a position in ALB in Q3 2025 and held it in 1 quarter. The position peaked at $428K in Q3 2025. 908 funds tracked by Wall St. Rank hold ALB as of Q4 2025.

SummitTX Capital reported no remaining Albemarle position as of Q4 2025 after selling out during the quarter.
SummitTX Capital sold 5,276 Albemarle shares in Q4 2025, an estimated $428K.
SummitTX Capital first reported a position in Albemarle in Q3 2025 and held it in 1 quarter.
SummitTX Capital's Albemarle position peaked at $428K in Q3 2025.
908 funds tracked by Wall St. Rank held Albemarle as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.